Search

everythinglearnresearchcommunity

for

Search:↓

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

ATP helps prevent skin damage from vandetanib by reducing stress.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Tofacitinib treatment for hair loss may worsen acne.

Ion sequential therapy improves heart function after a heart attack.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Isoginkgetin reduces inflammation in cells by blocking NF-κB activation.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.